InspireMD, Inc. (NASDAQ:NSPR) Q3 2024 Earnings Call Transcript
Operator: Good day, everyone, and welcome to the InspireMD Third Quarter 2024 Earnings Call. Currently, all participants are in a listen-only mod e.
Inspiremd Inc. (NSPR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 2,209,593 | $5,921,709 | +10% | 0.29% |
| 2. | OrbiMed Advisors Samuel Isaly | 2,133,405 | $5,717,525 | 0.1% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,860,405 | $4,967,281 | 0% | |
| 4. | Soleus Capital Guy Levy | 1,378,128 | $3,693,383 | 0.28% | |
| 5. | Velan Capital Adam Morgan | 904,029 | $2,422,798 | 2.26% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.53 | 50,000 | Director | 438,902 | 2023-11-30 | Filing | |
| $1.63 | 175,000 | Director | 248,534 | 2023-05-12 | Filing | |
| $1.63 | 61,249 | Director | 108,590 | 2023-05-12 | Filing | |
| $1.63 | 122,497 | Director | 122,497 | 2023-05-12 | Filing | |
| $1.63 | 61,249 | Director | 233,545 | 2023-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.18 | 65 | Director | 12,746 | 2018-12-11 | Filing | |
| $0.21 | 8 | Director | 0 | 2018-11-21 | Filing | |
| $2.64 | 597,300 | Director | 1,925,110 | 2013-11-26 | Filing | |
| $2.63 | 1,100 | Director | 2,522,410 | 2013-11-21 | Filing | |
| $2.68 | 1,000 | Director | 2,523,510 | 2013-11-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 925,194 | $2,599,795 | 2.14% | |
| 2. | 63,530 | $178,519 | 0% | |
| 3. | 30,000 | $84,300 | 0% | |
| 4. | 28,438 | $79,910 | 0% | |
| 5. | 27,262 | $76,000 | 0% |
News See All
InspireMD, Inc. (NASDAQ:NSPR) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Second Quarter 2024 Earnings Call. Currently, all participants' are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the InspireMD First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2. InspireMD, Inc.
InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript
InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.16, expectations were $-0.2.
InspireMD, Inc. (NASDAQ:NSPR) Q3 2023 Earnings Call Transcript
Operator: Good morning. And welcome to the InspireMD Third Quarter of 2023 Earnings Call. Currently, all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Second Quarter 2023 Earnings Call. Currently all participants are in a listen-only mode.
InspireMD, Inc. (NASDAQ:NSPR) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the InspireMD First Quarter 2023 Earnings Call. All participants will be in listen-only mode. [Operator Instructions].
InspireMD, Inc. (NASDAQ:NSPR) Q4 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Fourth Quarter and Full Year 2022 Earnings Call. Please note, this conference is being recorded.
InspireMD, Inc. (NASDAQ:NSPR) Q3 2022 Earnings Call Transcript
Operator: Good morning, and welcome to the InspireMD Third Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.